2013
DOI: 10.1371/journal.pone.0068937
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Wnt/β-Catenin Pathway in Monocytes Derived from Chronic Kidney Disease Patients

Abstract: Patients with chronic kidney disease (CKD) have significantly increased morbidity and mortality resulting from infections and cardiovascular diseases. Since monocytes play an essential role in host immunity, this study was directed to explore the gene expression profile in order to identify differences in activated pathways in monocytes relevant to the pathophysiology of atherosclerosis and increased susceptibility to infections. Monocytes from CKD patients (stages 4 and 5, estimated GFR <20 ml/min/1.73 m2) an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 42 publications
0
18
0
Order By: Relevance
“…This stringency may have precluded the identifi cation of many genes differentially expressed in the upper abdominal subcutaneous fat of FCHL patients at modest-moderate levels, especially as we implemented a stringent FDR threshold (1%) to minimize the risk of identifying false positives. Nonetheless, it is well established that microarray studies using even smaller patient cohorts than that used in the current study have successfully identifi ed important gene expression changes and the nature of the dysfunctional pathways underlying disease (47)(48)(49)(50)(51)(52). Indeed, our approach was vindicated in that we identifi ed 73 differentially expressed FCHL genes that also exhibited altered expression in the subcutaneous periumbilical fat of rather younger (38 ± 9.3 years of age), leaner (27 ± 2.4 kg/m 2 ), and healthier Mexican FCHL patients who had somewhat higher total cholesterol (6.8 ± 1.2 mmol/l) and triglyceride (4.7 ± 2.6 mmol/l) levels ( 7 ) than our patients ( Table 1 ), presumably because they were not on treatment with statins.…”
Section: Discussionmentioning
confidence: 95%
“…This stringency may have precluded the identifi cation of many genes differentially expressed in the upper abdominal subcutaneous fat of FCHL patients at modest-moderate levels, especially as we implemented a stringent FDR threshold (1%) to minimize the risk of identifying false positives. Nonetheless, it is well established that microarray studies using even smaller patient cohorts than that used in the current study have successfully identifi ed important gene expression changes and the nature of the dysfunctional pathways underlying disease (47)(48)(49)(50)(51)(52). Indeed, our approach was vindicated in that we identifi ed 73 differentially expressed FCHL genes that also exhibited altered expression in the subcutaneous periumbilical fat of rather younger (38 ± 9.3 years of age), leaner (27 ± 2.4 kg/m 2 ), and healthier Mexican FCHL patients who had somewhat higher total cholesterol (6.8 ± 1.2 mmol/l) and triglyceride (4.7 ± 2.6 mmol/l) levels ( 7 ) than our patients ( Table 1 ), presumably because they were not on treatment with statins.…”
Section: Discussionmentioning
confidence: 95%
“…In diabetic mice, Msx promotes the nuclear localization of β-catenin, enhances Wnt signaling and induces osteoblast differentiation and osteogenic calcification [24]. Alterations in the Wnt/β-catenin signaling pathway have been implicated in the development of CKD [35]. A recent study showed that Klotho, a coreceptor of fibroblast growth factor-23 that functions as an inhibitor of Wnt signaling, is deficient in CKD [36].…”
Section: Discussionmentioning
confidence: 99%
“…Genome-wide gene expression profiles were established from freshly isolated peripheral blood monocytes from CKD stage 4–5 patients and healthy subjects with a median age of 59 years. 27 (more details in Supplement Methods). …”
Section: Methodsmentioning
confidence: 99%